What Are Benign Lung Nodules and Benign Lung Tumors? A nodule is a "spot on the lung," seen on an X-ray or computed tomography (CT) scan. In fact, a nodule shows up on about one in every 500 chest ...
Please provide your email address to receive an email when new articles are posted on . The negative predictive value of a biomarker that detects benign vs. malignant nodules was more than 90% in men ...
Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti–EGFR-Based Therapy In a prospective study of 221 patients, training (n = ...
Value of a serum proteomic signature in the non-invasive evaluation of lung nodules. Background: There is no approved screening method for lung cancer and CT scanning has a high rate of false ...
Add Yahoo as a preferred source to see more of our stories on Google. Picture this: Your doctor orders an imaging test like a chest X-ray in preparation for an upcoming procedure, and the results show ...
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that three data presentations will ...
Benign metastasizing leiomyoma (BML) is a rare clinical entity predominantly observed in women with a history of uterine leiomyomas. Despite its designation as “benign”, BML manifests as multiple ...
Please provide your email address to receive an email when new articles are posted on . Use of an artificial intelligence program detected lung nodules up to 1 year before their detection by ...
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that the prospective, real-world ORACLE ...
OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive ...
ALAMEDA, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy diagnostic tests for the early detection of cancer, ...